,This is a citation overview for a set of 391 documents.,,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 49 (Of the 391 documents considered for the h-Index, 49 have been cited at least 49 times.)",,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,8580,829,810,1639,503,10722
2009,Polychlorinated biphenyls in bile of patients with biliary tract cancer,"Adenugba A., Beck A.J., Khan S.A., Taylor-Robinson S.D., Jane Cox I., Toledano M.B., Thillainayagam A.V., Bansi D.S., Thomas H.C., Gibson R.W.",456535,Chemosphere,76,6,0,0,0,0,0,0
2009,Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue,"Cobbold J.F.L., Cox R.D., Taylor-Robinson S.D., Cox I.J., Anstee Q.M., Goldin R.D., Williams H.R.T., Matthews H.C., North B.V., Absalom N., Thomas H.C., Thursz M.R.",1435221,Clinical Science,116,5,0,0,0,0,1,1
2008,NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: A review of 12 years experience in west London,"Kennedy P.T.F., Smith B., Brown A., Thomas H.C., Lee H.C., Jeyalingam L., Malik R., Karayiannis P., Muir D., Main J., Thursz M., Goldin R.",13596535,Antiviral Therapy,13,8,0,0,0,0,0,0
2008,Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study,"Forton D.M., Hamilton G., Allsop J.M., Grover V.P., Wesnes K., O'Sullivan C., Thomas H.C., Taylor-Robinson S.D.",1688278,Journal of Hepatology,49,3,0,0,0,0,5,5
2008,Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage?,"Godkin A., Ng W.F., Gallagher K., Betts G., Thomas H.C., Lechler R.I.",916749,Journal of Allergy and Clinical Immunology,121,5,0,0,1,1,3,4
2008,Effect of basal core promoter and pre-core mutations on hepatitis B virus replication,"Jammeh S., Tavner F., Watson R., Thomas H.C., Karayiannis P.",221317,Journal of General Virology,89,4,0,0,0,0,7,7
2008,"Reply to ""Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patients""",Thomas H.,1688278,Journal of Hepatology,48,3,0,0,0,0,0,0
2007,"Replicative competence of the T131I, K141E, and G145R surface variants of hepatitis B virus","Jammeh S., Thomas H.C., Karayiannis P.",221899,Journal of Infectious Diseases,196,7,0,0,1,1,0,1
2007,Best practice in the treatment of chronic hepatitis B: A summary of the European Viral Hepatitis Educational Initiative (EVHEI),Thomas H.C.,1688278,Journal of Hepatology,47,4,0,0,7,7,2,9
2007,Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection,"Hennig B.J., Hill A.V., Frodsham A.J., Hellier S., Knapp S., Yee L.J., Wright M., Zhang L., Thomas H.C., Thursz M.",14783223,Liver International,27,8,0,0,0,0,2,2
2007,Journal of Viral Hepatitis: Editorial,"Foster G.R., Karayiannis P., Lok A., Thomas H.C.",13520504,Journal of Viral Hepatitis,14,9,0,0,0,0,0,0
2007,Long-term follow-up of the hepatitis C HENCORE cohort: Response to therapy and occurrence of liver-related complications,"Pradat P., Esteban J.-I., Hadziyannis S., Rizzetto M., Thomas H., Manns M.P., Trepo C., Tillmann H.L., Sauleda S., Braconier J.-H., Saracco G., Thursz M., Goldin R., Winkler R., Alberti A.",13520504,Journal of Viral Hepatitis,14,8,0,0,1,1,4,5
2007,Journal of Viral Hepatitis: Editorial,"Thomas H.C., Foster G.R., Karayiannis P.",13520504,Journal of Viral Hepatitis,14,1,0,0,0,0,0,0
2007,Hepatitis B and D,Thomas H.C.,13573039,Medicine,35,1,0,0,0,0,0,0
2006,Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques [11],"Cobbold J.F.L., Wylezinska M., Cunningham C., Crossey M.E., Thomas H.C., Cox I.J., Patel N., Taylor-Robinson S.D.",175749,Gut,55,11,1,0,2,2,0,3
2006,Cost effectiveness of interferon ? or peginterferon ? with ribavirin for histologically mild chronic hepatitis C,"Grieve R., Roberts J., Wright M., Sweeting M., DeAngelis D., Rosenberg W., Bassendine M., Main J., Thomas H.",175749,Gut,55,9,6,8,2,10,4,20
2006,Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease,"Cox I.J., Sharif A., Cobbold J.F.L., Thomas H.C., Taylor-Robinson S.D.",10079327,World Journal of Gastroenterology,12,30,0,1,4,5,4,9
2006,Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.,"Wright M., Grieve R., Roberts J., Main J., Thomas H.C.",13665278,"Health technology assessment (Winchester, England)",10,21,1,4,4,8,2,11
2006,Hepatic vein transit time of SonoVue: A comparative study with levovist,"Lim A.K.P., Patel N., Eckersley R.J., Goldin R.D., Thomas H.C., Cosgrove D.O., Taylor-Robinson S.D., Blomley M.J.K.",338419,Radiology,240,1,0,4,3,7,5,12
2006,Health benefits of antiviral therapy for mild chronic hepatitis C: Randomized controlled trial and economic evaluation,"Wright M., Milson C., Basendine M., Collier J., Dusheiko G., Rosenburg W., Thursz M., Taylor-Robinson S., Naumov N., Tibbs C., Norris S., Grieve R., Roberts J., Main J., Thomas H.C., Alexander G., Freedman A., Dillon J., Mills P.",13665278,Health Technology Assessment,10,21,0,0,0,0,1,1
2006,Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease,"Grier S., Lim A.K.P., Patel N., Cobbold J.F.L., Thomas H.C., Cox I.J., Taylor-Robinson S.D.",10079327,World Journal of Gastroenterology,12,22,0,0,0,0,0,0
2006,Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence,"Frodsham A.J., Wright M., Chiaramonte M., Bell J.I., Graves M., Whittle H.C., Thomas H.C., Thursz M.R., Hill A.V.S., Zhang L., Dumpis U., Taib N.A.M., Best S., Durham A., Hennig B.J.W., Hellier S., Knapp S.",278424,Proceedings of the National Academy of Sciences of the United States of America,103,24,1,5,4,9,8,18
2006,Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis [4],"Cobbold J., Lim A., Wylezinska M., Cunningham C., Crossey M., Thomas H., Patel N., Cox J., Taylor-Robinson S.",2709139,Hepatology,43,6,0,3,1,4,0,4
2006,Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy,"Grover V.P.B., Dresner M.A., Forton D.M., Counsell S., Larkman D.J., Patel N., Thomas H.C., Taylor-Robinson S.D.",10079327,World Journal of Gastroenterology,12,18,0,7,2,9,7,16
2006,Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.,"Khan S.A., Taylor-Robinson S.D., Carmichael P.L., Habib N., Lemoine N.R., Thomas H.C.",10196439,International journal of oncology.,28,5,1,0,0,0,0,1
2006,Mild hepatitis C: Treat or monitor,"Main J., Thomas H.",13520504,Journal of Viral Hepatitis,13,5,0,0,0,0,0,0
2006,Central nervous system changes in hepatitis C virus infection,"Forton D.M., Taylor-Robinson S.D., Thomas H.C.",0954691X,European Journal of Gastroenterology and Hepatology,18,4,0,4,7,11,3,14
2006,Variations due to analysis technique in intracellular pH measurements in simulated and in vivo31P MR of the human brain,"Hamilton G., Allsop J.M., Patel N., Forton D.M., Thomas H.C., O'Sullivan C.P.A., Hajnal J.V., Taylor-Robinson S.D.",10531807,Journal of Magnetic Resonance Imaging,23,4,0,0,0,0,1,1
2006,The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice,"Vig P., Russo F.P., Edwards R.J., Tadrous P.J., Wright N.A., Thomas H.C., Alison M.R., Forbes S.J.",2709139,Hepatology,43,2,9,12,17,29,7,45
2006,Journal of Viral Hepatitis: Editorial,"Foster G.R., Karayiannis P., Thomas H.C.",13520504,Journal of Viral Hepatitis,13,1,0,0,0,0,0,0
2005,Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant,"Godkin A., Openshaw P., Thomas H.C.",13520504,Journal of Viral Hepatitis,12,6,0,0,0,0,0,0
2005,Cholangiocarcinoma,"Khan S.A., Thomas H.C., Davidson B.R., Taylor-Robinson S.D.",1406736,Lancet,366,9493,17,46,51,97,25,139
2005,A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection,"Forton D.M., Allsop J.M., Cox I.J., Hamilton G., Wesnes K., Thomas H.C., Taylor-Robinson S.D.",2699370,AIDS,19,3,1,3,13,16,2,19
2005,p53 mutations in human cholangiocarcinoma: A review,"Khan S.A., Thomas H.C., Toledano M.B., Cox I.J., Taylor-Robinson S.D.",14783223,Liver International,25,4,0,3,5,8,2,10
2005,Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer,"Khan S.A., Cox I.J., Thillainayagam A.V., Bansi D.S., Thomas H.C., Taylor-Robinson S.D.",0954691X,European Journal of Gastroenterology and Hepatology,17,7,4,1,5,6,4,14
2005,Can Doppler sonography grade the severity of hepatitis C-related liver disease?,"Lim A.K.P., Patel N., Eckersley R.J., Kuo Y.-T., Goldin R.D., Thomas H.C., Cosgrove D.O., Taylor-Robinson S.D., Blomley M.J.K.",0361803X,American Journal of Roentgenology,184,6,5,5,11,16,1,22
2005,In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: A Review of 1H and 31P MRS applications,"Khan S.A., Cox I.J., Hamilton G., Thomas H.C., Taylor-Robinson S.D.",14783223,Liver International,25,2,3,3,6,9,4,16
2005,Fatigue in primary biliary cirrhosis [1],"Forton D.M., Bassendine M., Jones D.E.J., Patel N., Oatridge A., Hamilton G., Hajnal J.V., Thomas H.C., Taylor-Robinson S.D., Prince M., Goldblatt J.",175749,Gut,54,3,0,0,1,1,0,1
2005,Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?,"Karayiannis P., Thomas H.C.",17434378,Nature Clinical Practice Gastroenterology and Hepatology,2,3,0,0,0,0,0,0
2005,Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice,"Hoare J., Waddington S., Thomas H.C., Coutelle C., McGarvey M.J.",1099498X,Journal of Gene Medicine,7,3,4,1,5,6,2,12
2005,Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: A multicentre randomized controlled trial,"Wright M., Millson C., Mills P.R., Bassendine M., Thomas H.C., Forton D., Main J., Goldin R., Torok E., Tedder R., Grant P., Thursz M., Naoumov N.",13520504,Journal of Viral Hepatitis,12,1,10,3,3,6,1,17
2005,Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C,"Lim A.K.P., Blomley M.J.K., Taylor-Robinson S.D., Patel N., Eckersley R.J., Goldin R.D., Hamilton G., Foster G.R., Thomas H.C., Cosgrove D.O.",175749,Gut,54,1,12,9,9,18,6,36
2005,Journal of Viral Hepatitis: Editorial,Thomas H.,13520504,Journal of Viral Hepatitis,12,1,0,0,0,0,0,0
2004,Hepatitis vaccines,"Karayiannis P., Main J., Thomas H.C.",71420,British Medical Bulletin,70, ,2,0,1,1,0,3
2004,Central nervous system involvement in hepatitis C virus infection,"Forton D.M., Thomas H.C., Taylor-Robinson S.D.",8857490,Metabolic Brain Disease,19, 3-4,6,4,8,12,1,19
2004,Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-?,"Luik A., Knapp S., Thursz M., Thomas H.C., Schlaak J.F.",10799907,Journal of Interferon and Cytokine Research,24,10,0,2,1,3,2,5
2004,How should we manage the patient?,"Main J., Thomas H.",13520504,Journal of Viral Hepatitis,11,1,0,1,0,1,1,2
2004,Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: Correlates of positivity and clinical relevance,"Yee L.J., Thursz M.R., Kelleher P., Goldin R.D., Marshall S., Thomas H.C., Alberti A., Chiaramonte M., Braconier J.-H., Hall A.J.",13520504,Journal of Viral Hepatitis,11,5,5,3,2,5,7,17
2004,Determining the precursor frequency of HBV nucleocapsid antigen-specific T cells.,"Waters J.A., Thomas H.C.",15431894,Methods in molecular medicine,96, ,0,0,0,0,0,0
2004,Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection,"Yee L.J., Knapp S., Burgner D., Hennig B.J.W., Frodsham A.J., Wright M., Thomas H.C., Hill A.V.S., Thurz M.R.",14664879,Genes and Immunity,5,3,7,1,3,4,1,12
2004,"Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants","Forton D.M., Karayiannis P., Mahmud N., Taylor-Robinson S.D., Thomas H.C.",0022538X,Journal of Virology,78,10,29,10,13,23,8,60
2004,Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels,"Forton D.M., Bassendine M., Jones D.E.J., Taylor-Robinson S.D., Patel N., Prince M., Oatridge A., Hamilton G., Goldblatt J., Allsop J.M., Hajnal J.V., Thomas H.C.",175749,Gut,53,4,13,8,9,17,1,31
2004,Erratum: Mechanisms of action of interferon and nucleoside analogues (Jouranl of Hepatology (2003) 39 (S93-S98)),"Thomas H., Foster G., Platis D.",1688278,Journal of Hepatology,40,2,0,0,0,0,0,0
2004,Journal of Viral Hepatitis: Editorial,"Thomas H.C., Foster G.R., Karayiannis P.",13520504,Journal of Viral Hepatitis,11,1,0,0,0,0,0,0
2003,"Association of Genetic Variants of the Chemokine Receptor CCR5 and Its Ligands, RANTES and MCP-2, with Outcome of HCV Infection","Hellier S., Thomas H.C., Thursz M., Hill A.V.S., Frodsham A.J., Hennig B.J.W., Klenerman P., Knapp S., Ramaley P., Satsangi J., Wright M., Zhang L.",2709139,Hepatology,38,6,38,19,21,40,8,86
2003,Hepatology in the UK,Thomas H.C.,2709139,Hepatology,38,5,0,0,0,0,0,0
2003,"EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)","De Franchis R., Rodes J., Rosenberg W., Valla D., Alberti A., Dusheiko G., Hadziyannis S., Marcellin P., Rizzetto M., Samuel D., Shouval D., Hadengue A., Alter M., Benhamou Y., Bonanni P., Bonino F., Bortolotti F., Bruix J., Brunetto M., Colombo M., Cooksley G., Craxi A., Lau G., Desmet V., Duclos P., Esteban R., Farci P., Fattovich G., Ferrari C., Heathcote J., Hoofnagle J., Liaw Y.-F., Locarnini S., Lavanchy D., Manns M., Namgyal P., Naoumov N., Pawlotsky J.-M., Perrillo R., Pol S., Pontisso P., Raimondo G., Roggendorf M., Schalm S., Lok A., Thomas H., Trepo C., Van Damme P., Will H., Wright T., Zeuzem S., Zoulim F., Day C., Levrero M., Nevens F., McIntyre N., Yurdaydin C., Mele A., Paumgartner G., Pietrangelo A.",1688278,Journal of Hepatology,39,1,128,23,20,43,16,187
2003,Mechanisms of action of interferon and nucleoside analogues,"Thomas H., Foster G., Platis D.",1688278,Journal of Hepatology,39,1,18,10,3,13,3,34
2003,Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection,"Knapp S., Thursz M.R., Hennig B.J.W., Frodsham A.J., Zhang L., Hellier S., Wright M., Goldin R., Hill A.V.S., Thomas H.C.",937711,Immunogenetics,55,6,30,13,11,24,5,59
2003,"Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: Roles of MxA, OAS-1 and PKR","Knapp S., Thomas H.C., Hill A.V.S., Thursz M.R., Yee L.J., Frodsham A.J., Hennig B.J.W., Hellier S., Zhang L., Wright M., Chiaramonte M., Graves M.",14664879,Genes and Immunity,4,6,27,12,10,22,7,56
2003,Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection,"Wright M., Thomas H., Thursz M., Goldin R., Hellier S., Knapp S., Frodsham A., Hennig B., Hill A., Apple R., Cheng S.",175749,Gut,52,8,20,9,10,19,3,42
2003,Quality of life and cognitive function in chronic hepatitis C - What to measure?,"Forton D.M., Thomas H.C., Taylor-Robinson S.D.",1688278,Journal of Hepatology,39,2,7,0,0,0,1,8
2003,"DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma","Khan S.A., Carmichael P.L., Taylor-Robinson S.D., Habib N., Thomas H.C.",175749,Gut,52,4,5,1,1,2,3,10
2003,Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: A cross sectional and longitudinal study,"Wright M., Goldin R., Fabre A., Lloyd J., Thomas H., Trepo C., Pradat P., Thursz M.",175749,Gut,52,4,25,9,5,14,5,44
2003,Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects,"Gaud U., Langer B., Petropoulou T., Thomas H.C., Karayiannis P.",1466615,Journal of Medical Virology,69,3,7,3,1,4,0,11
2003,Cerebral dysfunction in chronic hepatitis C infection,"Forton D.M., Taylor-Robinson S.D., Thomas H.C.",13520504,Journal of Viral Hepatitis,10,2,26,9,10,19,4,49
2003,Quantitative versus morphological assessment of liver fibrosis: Semi-quantitative scores are more robust than digital image fibrosis area estimation,"Wright M., Thursz M., Pullen R., Thomas H., Goldin R.",14783223,Liver International,23,1,10,1,4,5,0,15
2003,MR-guided laser thermal ablation of primary and secondary liver tumours,"Dick E.A., Joarder R., De Jode M., Taylor-Robinson S.D., Thomas H.C., Foster G.R., Gedroyc W.M.W.",99260,Clinical Radiology,58,2,20,4,4,8,1,29
2002,The Journal of Viral Hepatitis goes electronic,"Foster G., Thomas H.",13520504,Journal of Viral Hepatitis,9,2,0,0,0,0,0,0
2002,"Changing international trends in mortality rates for liver, biliary and pancreatic tumours","Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C.",1688278,Journal of Hepatology,37,6,47,25,23,48,18,113
2002,New insights into hepatitis C,"Forton D.M., Wright M., Knapp S., Thursz M.R., Taylor-Robinson S.D., Thomas H.C.",14702118,Clinical Medicine,2,6,2,0,0,0,0,2
2002,Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document,"Khan S.A., Wasan H., Ramaya C., Davidson B.R., Goldin R., Pereira S.P., Rosenberg W.M.C., Taylor-Robinson S.D., Thillainayagam A.V., Thomas H.C., Thursz M.R.",175749,Gut,51,6,86,21,47,68,16,170
2002,Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection,"Hennig B.J.W., Hill A.V.S., Hellier S., Frodsham A.J., Zhang L., Klenerman P., Knapp S., Wright M., Thomas H.C., Thursz M.",14664879,Genes and Immunity,3,6,17,6,5,11,3,31
2002,Evolution of epitope-specific memory CD4+ T cells after clearance of hepatitis C virus,"Godkin A.J., Thomas H.C., Openshaw P.J.",221767,Journal of Immunology,169,4,32,6,12,18,5,55
2002,Pancreatic stem cells,"Forbes S., Vig P., Poulsom R., Thomas H., Alison M.",223417,Journal of Pathology,197,4,108,18,21,39,6,153
2002,Ablative therapy for liver tumours,"Dick E.A., Taylor-Robinson S.D., Thomas H.C., Gedroyc W.M.W.",175749,Gut,50,5,37,3,3,6,1,44
2002,Reduced quality of life in hepatitis C - Is it all in the head?,"Forton D.M., Taylor-Robinson S.D., Thomas H.C.",1688278,Journal of Hepatology,36,3,15,3,2,5,0,20
2002,Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease,"Forton D.M., Thomas H.C., Murphy C.A., Allsop J.M., Foster G.R., Main J., Wesnes K.A., Taylor-Robinson S.D.",2709139,Hepatology,35,2,108,20,26,46,14,168
2001,Treatment of chronic viral hepatitis,"Wright M., Main J., Thomas H.C.",9563202,Antiviral Chemistry and Chemotherapy,12,4,5,1,0,1,0,6
2001,Erratum: Treatment of chronic viral hepatitis (Antiviral Chemistry and Chemotherapy 12:4 (201-212)),"Wright M., Main J., Thomas H.C.",9563202,Antiviral Chemistry and Chemotherapy,12,5,0,0,0,0,0,0
2001,Evidence for a cerebral effect of the hepatitis C virus,"Forton D.M., Allsop J.M., Main J., Foster G.R., Thomas H.C., Taylor-Robinson S.D.",1406736,Lancet,358,9275,87,13,17,30,10,127
2001,Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998,"Taylor-Robinson S.D., Toledano M.B., Arora S., Keegan T.J., Hargreaves S., Beck A., Khan S.A., Elliott P., Thomas H.C.",175749,Gut,48,6,61,10,23,33,12,106
2001,Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients,"Godkin A., Jeanguet N., Thursz M., Openshaw P., Thomas H.",142980,European Journal of Immunology,31,5,31,9,3,12,1,44
2001,"Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient","Seddigh-Tonekaboni S., Lim W.L., Young B., Hou J.-L., Waters J., Luo K.-X., Thomas H.C., Karayiannis P.",13520504,Journal of Viral Hepatitis,8,2,6,3,1,4,1,11
2001,HCV in healthcare workers: A lightning strike,Thomas H.C.,175749,Gut,48,1,0,0,0,0,0,0
2000,"Sequence, expression and reconstitution of an HCV genome from a British isolate derived from a single blood donation","Kumar U., Tuthill T., Thomas H.C., Monjardino J.",13520504,Journal of Viral Hepatitis,7,6,2,1,0,1,0,3
2000,Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: A phosphorus-31 MR spectroscopy study,"Patel N., Forton D.M., Coutts G.A., Thomas H.C., Taylor-Robinson S.D.",8857490,Metabolic Brain Disease,15,3,4,0,0,0,1,5
2000,Drug-resistant viral hepatitis,"Wright M., Main J., Thomas H.C.",1634453,Journal of Infection,41,1,2,0,0,0,0,2
2000,Epidemiology of hepatitis C virus infection in seven European Union countries: A critical analysis of the literature,"Touzet S., Tillmann H., Alberti A., Braconier J.-H., Esteban J.-I., Hadziyannis S.J., Manns M.P., Saracco G., Thomas H.C., Trepo C., Kraemer L., Colin C., Pradat P., Lanoir D., Bailly F., Coppola R.C., Sauleda S., Thursz M.R.",0954691X,European Journal of Gastroenterology and Hepatology,12,6,30,2,5,7,3,40
2000,Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy,"Pradat P., Alberti A., Braconier J.-H., Esteban J.-I., Hadziyannis S., Manns M., Rizzetto M., Thomas H.C., Trepo C., Chossegros P., Bailly F., Pontisso P., Saracco G., Sauleda S., Thursz M., Tillmann H., Vlassopoulou H.",13520504,Journal of Viral Hepatitis,7,3,10,1,1,2,0,12
2000,Therapeutic options for HCV - Management of the infected individual,"Foster G.R., Thomas H.C.",15216918,Bailliere's Best Practice and Research in Clinical Gastroenterology,14,2,5,0,0,0,0,5
2000,Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen,"Seddigh-Tonekaboni S., Waters J.A., Jeffers S., Gehrke R., Ofenloch B., Horsch A., Hess G., Thomas H.C., Karayiannis P.",1466615,Journal of Medical Virology,60,2,35,8,2,10,3,48
1999,Influence of MHC class II genotype on outcome of infection with hepatitis C virus,"Thursz M., Yallop R., Goldin R., Trepo C., Thomas H.C.",1406736,Lancet,354,9196,132,17,11,28,10,170
1999,Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C,"Thomas H.C., Torok M.E., Forton D.M., Taylor-Robinson S.D.",1695185,"Journal of Hepatology, Supplement",31,1,45,4,2,6,2,53
1999,"Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response","Paterson M., Laxton C.D., Thomas H.C., Ackrill A.M., Foster G.R.",165085,Gastroenterology,117,5,51,8,3,11,0,62
1999,Increased mortality from liver cancer in England and Wales is not related to hepatitis C [2],"Taylor-Robinson S.D., Thomas H.C., Arora S., Hargreaves S.",9598146,British Medical Journal,319,7210,3,0,3,3,1,7
1999,"MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: Technique and early progress","Jode M.G.D., Lamb G.M., Thomas H.C., Taylor-Robinson S.D., Gedroyc W.M.W.",1688278,Journal of Hepatology,31,2,31,0,2,2,1,34
1999,Summary of the First International Symposium on Viral Hepatitis,"Gonzalez-Peralta R.P., Galasso G.J., Poynard T., Schalm S., Thomas H.C., Wright T.L.",1663542,Antiviral Research,42,2,3,0,1,1,0,4
1999,Hepatitis G virus/GBV-C persistence: Absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes,"Zampino R., Pickering J., Iqbal M., Gaud U., Thomas H.C., Karayiannis P.",13520504,Journal of Viral Hepatitis,6,3,6,1,2,3,0,9
1999,A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C,"Zeuzem S., Yap S.H., Koff R.S., Thomas H.C., Hopf U., Carreno V., Diago M., Shiffman M., Grune S., Dudley F.J., Rakhit A., Rittweger K.",2709139,Hepatology,29,4,43,3,2,5,1,49
1999,Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy.,"Thomas H.C., Torok M.E., Foster G.R.",2709139,"Hepatology (Baltimore, Md.)",29,4,6,0,0,0,0,6
1999,Severe exacerbation of liver disease during pregnancy in a thalassemic GBV-C/HGV-positive patient and neonatal hepatitis in offspring,"Horsmans Y., Geubel A.P., Karayiannis P., Christophe J.L., Pickering J.M., Debauche C., Cornu C., Rahier J., Hess G., Thomas H.C.",1466615,Journal of Medical Virology,57,2,3,0,0,0,0,3
1998,Mechanism of emergence of hepatitis B virus escape variants: Approaches to prevention,Thomas H.C.,13520504,Journal of Viral Hepatitis,5,2,3,0,0,0,0,3
1998,Treatment of chronic viral hepatitis,"Main J., McCarron B., Thomas H.C.",9563202,Antiviral Chemistry and Chemotherapy,9,6,16,2,0,2,0,18
1998,Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: Evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy,"Honkoop P., De Man R.A., Niesters H.G.M., Main J., Nevens F., Thomas H.C., Fevery J., Tyrrell D.L., Schalm S.W.",13520504,Journal of Viral Hepatitis,5,5,33,3,0,3,1,37
1998,Natural history and molecular biology of hepatitis G virus/GB virus C,"Karayiannis P., Pickering J., Zampino R., Thomas H.C.",9280197,Clinical and Diagnostic Virology,10, 2-3,9,1,0,1,1,11
1998,Summary of the III international consensus symposium on combined antiviral therapy,"Stuart J.W.T.C., Boucher C.A.B., Cooper D.A., Galasso G.J., Richman D.D., Thomas H.C., Whitley R.J.",1663542,Antiviral Research,38,2,9,0,0,0,0,9
1998,Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients,"Booth J.C.L., Kumar U., Webster D., Monjardino J., Thomas H.C.",2709139,Hepatology,27,1,75,8,4,12,4,91
1998,Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis,"Foster G.R., Goldin R.D., Thomas H.C., Owens D.K.",2709139,Hepatology,27,1,239,29,29,58,18,315
1998,Erratum: Heterozygote advantage for HLA class-II type in hepatitis B virus infection (Nature Genetics (1997) 17 (10-11)),"Thursz M.R., Thomas H.C., Greenwood B.M., Hill A.V.S.",10614036,Nature Genetics,18,1,0,0,0,0,0,0
1998,Hepatitis G virus does not cause significant liver disease after liver transplantation,"Karayiannis P., Brind A.M., Pickering J., Mathew J., Burt A.D., Hess G., Bassendine M.F., Thomas H.C.",13520504,Journal of Viral Hepatitis,5,1,7,0,0,0,0,7
1998,Molecular and therapeutic advances in the management of chronic hepatitis B and C,"McCarron B., Main J., Thomas H.C.",9517375,Current Opinion in Infectious Diseases,11,5,1,0,0,0,0,1
1998,A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies,"Waters J.A., Bailey C., Love C., Thomas H.C.",1466615,Journal of Medical Virology,54,1,9,0,0,0,0,9
1997,Host factors in chronic viral hepatitis,"Thursz M.R., Thomas H.C.",2728087,Seminars in Liver Disease,17,4,13,1,0,1,0,14
1997,HIV and hepatotropic viruses: Interactions and treatments,"McCarron B., Main J., Thomas H.C.",9564624,International Journal of STD and AIDS,8,12,1,1,1,2,0,3
1997,Immunogenetics of hepatitis B virus infection.,"Thomas H.C., Thursz M.R.",13520504,Journal of viral hepatitis,4, ,2,0,0,0,0,2
1997,Future approaches to treatment of chronic hepatitis B and hepatitis C infection.,"Thomas H.C., Waters J.A.",13520504,Journal of viral hepatitis,4, ,4,0,0,0,0,4
1997,The precore sequence of hepatitis B virus is required for nuclear localization of the core protein,"Aiba N., Mcgarvey M.J., Waters J., Hadziyannis S.J., Thomas H.C., Karayiannis P.",2709139,Hepatology,26,5,8,0,0,0,0,8
1997,"Increase in primary liver cancer in the UK, 1979-94 [3]","Taylor-Robinson S.D., Foster G.R., Arora S., Hargreaves S., Thomas H.C.",1406736,Lancet,350,9085,198,22,32,54,24,276
1997,Current status of hepatitis G virus (GBV-C) in transfusion: Is it relevant?,"Karayiannis P., Thomas H.C.",429007,Vox Sanguinis,73,2,19,1,0,1,0,20
1997,Management of chronic hepatitis C: Clinical audit of biopsy based management algorithm,"Foster G.R., Goldin R.D., Main J., Murray-Lyon I., Hargreaves S., Thomas H.C.",9598146,British Medical Journal,315,7106,53,0,1,1,1,55
1997,Heterozygote advantage for HLA class-II type in hepatitis B virus infection.,"Thursz M.R., Thomas H.C., Greenwood B.M., Hill A.V.",10614036,Nature genetics,17,1,122,13,10,23,9,154
1997,Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C,"Fattovich G., Thomas H., Realdi G., Corrocher R., Schalm S.W., Giustina G., Degos F., Diodati G., Tremolada F., Nevens F., Almasio P., Solinas A., Brouwer J.T.",1688278,Journal of Hepatology,27,1,118,11,7,18,1,137
1997,Summary of the II International Consensus Symposium on Combined Antiviral Therapy and Implications for future therapies,"De Jong M.D., Boucher C.A.B., Cooper D.A., Galasso G.J., Gazzard B., Lange J.M.A., Montaner J.S., Richman D.D., Thomas H.C.",1663542,Antiviral Research,35,2,5,0,0,0,0,5
1997,"Identification, prevalence and aspects of molecular biology of hepatitis G virus.","Thomas H.C., Pickering J., Karayiannis P.",13520504,Journal of viral hepatitis,4, ,4,0,0,0,0,4
1997,The relationship of histology to genotype in chronic HCV infection,"Booth J.C.L., Foster G.R., Levine T., Thomas H.C., Goldin R.D.",1069543,Liver,17,3,17,1,0,1,1,19
1997,Mapping of the cellular immune responses to woodchuck hepatitis core antigen epitopes in chronically infected woodchucks,"Shanmuganathan S., Waters J.A., Karayiannis P., Thursz M., Thomas H.C.",1466615,Journal of Medical Virology,52,2,9,0,0,0,0,9
1997,Predicted secondary structure of the hepatitis G virus and GB virus-A 5? untranslated regions consistent with an internal ribosome entry site,"Pickering J.M., Thomas H.C., Karayiannis P.",13520504,Journal of Viral Hepatitis,4,3,18,0,0,0,0,18
1997,"Hepatitis G virus: Identification, prevalence and unanswered questions","Karayiannis P., Thomas H.C.",175749,Gut,40,3,20,0,0,0,1,21
1997,Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species,"Alexopoulou A., Karayiannis P., Hadziyannis S.J., Aiba N., Thomas H.C.",1688278,Journal of Hepatology,26,4,15,3,1,4,2,21
1997,Hepatitis G virus infection.,"Karayiannis P., Pickering J., Chiaramonte M., Thomas H.C.",1406736,Lancet,349,9056,8,0,0,0,0,8
1997,"Expression, purification, and partial characterization of HCV RNA polymerase","Yuan Z.-H., Kumar U., Thomas H.C., Wen Y.-M., Monjardino J.",0006291X,Biochemical and Biophysical Research Communications,232,1,53,0,3,3,0,56
1997,Hepatitis G virus infection (multiple letters) [13],"Karayiannis P., Pickering J., Chiaramonte M., Thomas H.C., Schleicher S., Normann A., Gregor M., Hess G., Flehmig B.",1406736,Lancet,349,9056,6,0,1,1,0,7
1997,Genetic diversity between hepatitis G virus isolates: Analysis of nucleotide variation in the NS-3 and putative 'core' peptide genes,"Pickering J.M., Thomas H.C., Karayiannis P.",221317,Journal of General Virology,78,1,51,1,0,1,0,52
1997,Hepatitis G virus infection: Clinical characteristics and response to interferon,"Karayiannis P., Thomas H.C., Hadziyannis S.J., Kim J., Pickering J.M., Piatak M., Hess G., Yun A., McGarvey M.J., Wages J.",13520504,Journal of Viral Hepatitis,4,1,38,1,0,1,0,39
1997,Markers and mapping: We are all geneticists now,"Jones N., Ougham H., Thomas H.",0028646X,New Phytologist,137,1,29,1,3,4,4,37
1996,Different relative activities of human cell-derived interferon-? subtypes: IFN-?8 has very high antiviral potency,"Foster G.R., Rodrigues O., Ghouze F., Schulte-Frohlinde E., Testa D., Liao M.J., Stark G.R., Leadbeater L., Thomas H.C.",10799907,Journal of Interferon and Cytokine Research,16,12,65,8,3,11,4,80
1996,Hepatitis G virus: Identification and prevalence,"Karayiannis P., Thomas H.C.",14623935,Hospital Medicine,56,5,0,0,0,0,0,0
1996,Hepatitis G virus: Identification and prevalence,"Karayiannis P., Thomas H.C.",71064,British Journal of Hospital Medicine,56,5,5,0,0,0,0,5
1996,"Viral hepatitis, new viruses and therapies","McCarron B., Main J., Thomas H.C.",9517375,Current Opinion in Infectious Diseases,9,5,1,0,0,0,0,1
1996,Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection,"Thomas H.C., Foster G.R., Sumiya M., Mc Intosh D., Jack D.L., Turner M.W., Summerfield J.A.",1406736,Lancet,348,9039,67,6,8,14,0,81
1996,Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study,"Dusheiko G., Bassendine M., Norkrans G., Cuypers T., Lelie N., Telfer P., Watson J., Weegink C., Sillikens P., Weiland O., Main J., Thomas H., Reichard O., Lee C., Dhillon A., Rassam S., Fryden A., Reesink H.",1688278,Journal of Hepatology,25,5,206,14,7,21,6,233
1996,Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: A specific liver disease,"Colombatto P., Pagni R., Karayiannis P., Thomas H.C., Hess G., Bonino F., Brunetto M.R., Randone A., Civitico G., Monti Gorin J., Dolci L., Medaina N., Oliveri F., Verme G., Marchiaro G.",13520504,Journal of Viral Hepatitis,3,6,41,0,1,1,0,42
1996,Hepatitis C and bile duct loss,"Goldin R.D., Patel N.K., Thomas H.C.",219746,Journal of Clinical Pathology,49,10,13,0,0,0,0,13
1996,Pathophysiology and treatment of hepatitis C,"Thomas H.C., Booth J., Brown J.",126667,Drugs,52,2,5,0,0,0,0,5
1996,Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis,"Carman W.F., Thomas H.C., Manns M.P., Trautwein C., Van Deursen F.J., Colman K., Dornan E., Mcintyre G., Waters J., Kliem V., Muller R.",2709139,Hepatology,24,3,113,4,3,7,2,122
1996,"A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection","Main J., Brown J.L., Howells C., Galassini R., Crossey M., Karayiannis P., Georgiou P., Atkinson G., Thomas H.C.",13520504,Journal of Viral Hepatitis,3,4,93,1,0,1,0,94
1996,Pathogenesis of chronic hepatitis C and associated clinical manifestations,"Booth J.C.L., Thomas H.C.",9503528,Bailliere's Clinical Gastroenterology,10,2,8,0,0,0,0,8
1996,Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: Genetic variability and its potential role in disease pathogenicity,"Alexopoulou A., Karayiannis P., Hadziyannis S.J., Hou J., Pickering J., Luo K., Thomas H.C.",13520504,Journal of Viral Hepatitis,3,4,14,0,1,1,1,16
1996,Viral dynamics in hepatitis B virus infection,"Nowak M.A., Bonhoeffer S., Hill A.M., Boehme R., Thomas H.C., Mcdade H.",278424,Proceedings of the National Academy of Sciences of the United States of America,93,9,272,29,24,53,17,342
1996,Granulomas and hepatitis C,"Goldin R.D., Levine T.S., Foster G.R., Thomas H.C.",3090167,Histopathology,28,3,23,2,3,5,1,29
1996,The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection,"McGarvey M.J., Goldin R.D., Karayiannis P., Thomas H.C.",13520504,Journal of Viral Hepatitis,3,2,5,0,0,0,0,5
1996,Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent,"Linnen J., Hadziyannis S., Karayiannis P., Fung K., Nakatsuji Y., Shin J.W.-K., Young L., Piatak Jr. M., Hoover C., Fernandez J., Chen S., Wages Jr. J., Zou J.-C., Morris T., Hyams K.C., Ismay S., Lifson J.D., Hess G., Foung S.K.H., Thomas H., Bradley D., Margolis H., Zhang-Keck Z.-Y., Kim J.P., Fry K.E., Krawczynski K.Z., Alter H., Koonin E., Gallagher M., Alter M.",368075,Science,271,5248,1141,18,13,31,8,1180
1996,Minocycline and hepatitis [2],"Hardman C.M., Leonard J.N., Thomas H.C., Goldin R.",3076938,Clinical and Experimental Dermatology,21,3,6,0,0,0,0,6
1995,Hepatitis B e antigen negative chronic active hepatitis: Hepatitis B virus core mutations occur predominantly in known antigenic determinants,"Carman W.F., Thursz M., Hadziyannis S., McIntyre G., Colman K., Gioustoz A., Fattovich G., Alberti A., Thomas H.C.",13520504,Journal of Viral Hepatitis,2,2,34,4,2,6,1,41
1995,Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks,"Yang A., Karayiannis P., Thomas H., Monjardino J.",221317,Journal of General Virology,76,12,3,0,0,0,0,3
1995,Precore and X region mutants in hepatitis B virus infections among renal dialysis patients,"Feitelson M.A., Duan L.-X., Guo J., Horiike N., McIntyre G., Blumberg B.S., Thomas H.C., Carman W.",13520504,Journal of Viral Hepatitis,2,1,13,0,0,0,0,13
1995,Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: Detection of an anti-VP0 response in convalescent-phase sera,"Karayiannis P., O'Rourke S., Watts R., Waters J., Hill V., Carman W.F., Thomas H.C.",1071412X,Clinical and Diagnostic Laboratory Immunology,2,6,0,0,1,1,0,1
1995,Hepatitis B virus precore/core variation and interferon therapy,"Fattovich G., Mcintyre G., Thursz M., Colman K., Giuliano G., Alberti A., Thomas H.C., Carman W.F.",2709139,Hepatology,22,5,49,6,1,7,1,57
1995,Base changes at positions 1014 and 578 of delta virus RNA in Greek isolates maintain base pair in rod conformation with efficient RNA editing,"Yang A., Papaioannou C., Hadzyannis S., Thomas H., Monjardino J.",1466615,Journal of Medical Virology,47,2,9,0,0,0,1,10
1995,"Dual-centre, double-blind, randomised trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B","Giacchino R., Kariayannis P., Terragna A., Thomas H.C., Main J., Timitilli A., Giambartolomei G., Facco F., Cirillo C., Jacyna M.R., Brook M.G., Callea F.",1069543,Liver,15,3,15,0,1,1,0,16
1995,Hepatitis C virus Type I(1a) in Northern China,"Niu J., Kumar U., Pan Y., Liu Y., Zhan Q., Thomas H., Monjardino J.",1466615,Journal of Medical Virology,46,1,2,0,0,0,0,2
1995,Chronic hepatitis C virus infections: Predictive value of genotype and level of viraemia on disease progression and response to interferon ?,"Booth J.C.L., Foster G.R., Kumar U., Galassini R., Goldin R.D., Brown J.L., Thomas H.C.",175749,Gut,36,3,62,0,0,0,0,62
1995,Cytotoxic T cell responses in patients with chronic hepatitis B virus infection undergoing HBe antigen/antibody seroconversion,"Waters J.A., O'Rourke S., Schlict H.-J., Thomas H.C.",99104,Clinical and Experimental Immunology,102,2,15,0,0,0,1,16
1995,Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant,"Booth J.C.L., Goldin R.D., Brown J.L., Karayiannis P., Thomas H.C.",1688278,Journal of Hepatology,22,4,21,0,1,1,2,24
1995,A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers,"Hou J., Karayiannis P., Waters J., Luo K., Liang C., Thomas H.C.",2709139,Hepatology,21,2,55,6,2,8,4,67
1995,The management of chronic hepatitis C virus infection,"Booth J.C.L., Brown J.L., Thomas H.C.",175749,Gut,37,4,33,0,0,0,1,34
1995,Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: Importance of host factors,"Karayiannis P., Alexopoulou A., Hadziyannis S., Thursz M., Watts R., Seito S., Thomas H.C.",2709139,Hepatology,22,6,44,2,2,4,3,51
1995,Association of hepatitis B surface antigen carriage with severe malaria in Gambian children,"Thursz M.R., Kwiatkowski D., Torok M.E., Allsopp C.E.M., Greenwood B.M., Whittle H.C., Thomas H.C., Hill A.V.S.",10788956,Nature Medicine,1,4,17,0,3,3,0,20
1995,Association between an MHC class II allele and clearance of hepatitis B virus in the gambia,"Thursz M.R., Kwiatkowski D., Allsopp C.E.M., Greenwood B.M., Thomas H.C., Hill A.V.S.",284793,New England Journal of Medicine,332,16,206,14,14,28,7,241
1995,The emergence of envelope and precore/core variants of hepatitis B virus: The potential role of antibody selection,Thomas H.C.,1695185,"Journal of Hepatology, Supplement",22,1,13,0,0,0,0,13
1995,How to improve the results from interferon treatment of hepatitis C virus infection,"Thomas H.C., Foster G.R., Booth J.",9565272,Interferons and Cytokines,,26,1,0,0,0,0,1
1995,Pseudomembranous colitis following clarithromycin therapy,"Teare J.P., Booth J.C.L., Brown J.L., Martin J., Thomas H.C.",0954691X,European Journal of Gastroenterology and Hepatology,7,3,28,0,2,2,0,30
1995,Hepatitis C virus replication in hepatocellular carcinoma,"Niu J., Kumar U., Monjardino J., Goldin R., Rosin D., Thomas H.C.",219746,Journal of Clinical Pathology,48,9,7,0,1,1,0,8
1994,Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.,"Thomas H.C., Lok A.S., Carreno V., Farrell G., Tanno H., Perez V., Dusheiko G.M., Cooksley G., Ryff J.C.",13520504,Journal of viral hepatitis,1,2,31,1,1,2,0,33
1994,Effects of hepatitis B and hepatitis C virus replication on the actions of interferon,"Foster G.R., Thomas H.C.",1663542,Antiviral Research,24, 2-3,4,0,0,0,0,4
1994,Interferon (IFN)-?2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-?2a therapy,"Crowe J.S., Thursz M., Lok A.S., Gewert D.R., Barber K.A., Lewis A.P., Sims M.J., Davies S.L., Salom C.L., Wood J., Thomas H.C.",221899,Journal of Infectious Diseases,169,4,11,1,0,1,0,12
1994,Treatment with interferon reduces viraemia [7],"Foster G.R., Thomas H.C.",9598146,British Medical Journal,308,6945,0,0,0,0,0,0
1994,Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient,"Kumar U., Monjardino J., Thomas H.C.",165085,Gastroenterology,106,4,103,3,3,6,1,110
1994,Hepatitis delta virus replication in vitro is not affected by interferon-? or -? despite intact cellular responses to interferon and dsRNA,"McNair A.N.B., Cheng D., Monjardino J., Thomas H.C., Kerr I.M.",221317,Journal of General Virology,75,6,8,0,0,0,0,8
1994,In situ hybridization studies of hepatitis A viral RNA in patients with acute hepatitis A,"Taylor M., Goldin R.D., Ladva S., Scheuer P.J., Thomas H.C.",1688278,Journal of Hepatology,20,3,6,0,0,0,0,6
1994,Envelope and precore/core variants of hepatitis B virus,"Thomas H.C., Carman W.F.",8898553,Gastroenterology Clinics of North America,23,3,9,0,0,0,1,10
1993,Implications of genetic variation on the pathogenesis of hepatitis B virus infection.,"Carman W.F., Thomas H.C.",9391983,Archives of virology. Supplementum,8, ,4,0,0,0,0,4
1993,Treatment of hepatitis C,"Jacyna M.R., Thomas H.C.",10529276,Reviews in Medical Virology,3,4,2,0,0,0,0,2
1993,Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus,"Karayiannis P., Saldanha J., Jackson A.M., Luther S., Goldin R., Monjardino J., Thomas H.C.",1466615,Journal of Medical Virology,41,3,18,0,1,1,1,20
1993,Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy,"Foster G.R., Goldin R.D., Hay A., McGarvey M.J., Stark G.R., Thomas H.C.",2709139,Hepatology,17,5,9,1,1,2,0,11
1993,Viral genetic variation: Hepatitis B virus as a clinical example,"Carman W., Thomas H., Domingo E.",1406736,Lancet,341,8841,102,1,3,4,0,106
1993,Decreased contact factor mediated fibrinolysis in cirrhosis,"Cohen H., Hunt J.B., Dixit M., Kanwar S., Thomas H.C.",71048,British Journal of Haematology,85,3,8,1,0,1,0,9
1993,Hepatitis delta virus and the host response: current status and future perspectives.,"Thomas H.C., Karayiannis P., Monjardino J., McNair A.",3617742,Progress in clinical and biological research,382, ,0,0,0,0,0,0
1993,Recent advances in the molecular biology of hepatitis B virus: Mutant virus and the host response,"Foster G.R., Thomas H.C.",175749,Gut,34,1,7,1,0,1,0,8
1993,"Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculoviruses, controls HDV superinfection.","Karayiannis P., Saldanha J., Monjardino J., Jackson A., Luther S., Thomas H.C.",3617742,Progress in clinical and biological research,382, ,5,0,0,0,0,5
1993,Emergence of the long form of hepatitis delta virus antigen in transfected cells after intrahepatic transfection and during natural infection.,"Yang A., Karayiannis P., Cheng D., Hadziyannis S.J., Thomas H., Monjardino J.",3617742,Progress in clinical and biological research,382, ,0,0,0,0,0,0
1993,Hepatitis delta virus and the interferon system.,"McNair A.N., Monjardino J., Cheng D., Thomas H.C.",3617742,Progress in clinical and biological research,382, ,4,0,0,0,0,4
1993,Characterization of stable hepatitis delta expressing hepatoma cell lines: effect of HDAg on cell growth.,"Cheng D., Yang A., Thomas H., Monjardino J.",3617742,Progress in clinical and biological research,382, ,4,0,0,0,1,5
1993,Intraperitoneal haemorrhage from anterior abdominal wall varices,"Hunt J.B., Appleyard M., Thursz M., Carey P.D., Guillou P.J., Thomas H.C.",325473,Postgraduate Medical Journal,69,812,2,0,1,1,0,3
1993,Short report: Prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection,"Brook M.G., Main J., Yap I., Chan G., Karayiannis P., Crossey M., Thomas H.C.",2692813,Alimentary Pharmacology and Therapeutics,7,3,2,0,0,0,0,2
1993,Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection,"Kumar U., Brown J., Monjardino J., Thomas H.C.",221899,Journal of Infectious Diseases,167,3,32,0,0,0,0,32
1993,Primary liver lymphoma associated with primary biliary cirrhosis,"Goldin R., Sayer J., Wilkins M., Price P., Thomas H.",3090167,Histopathology,22,2,16,1,1,2,0,18
1992,The host immune response may be responsible for selection of envelope and precore/core variants of HBV.,"Thomas H.C., Carman W.F.",1060913X,Progress in liver diseases,10, ,2,0,0,0,0,2
1992,Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant,"Waters J.A., Kennedy M., Voet P., Hauser P., Petre J., Carman W., Thomas H.C.",219738,Journal of Clinical Investigation,90,6,95,6,1,7,2,104
1992,Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis,"Scully L.J., Karayiannis P., Thomas H.C.",1632116,Digestive Diseases and Sciences,37,11,6,1,0,1,0,7
1992,The diagnosis and management of viral hepatitis.,"Main J., Jacyna M.R., Thomas H.C.",13509349,Communicable disease report. CDR review,2,10,0,0,0,0,0,0
1992,Biological standards for hepatitis B virus assays,"Gerken G., Gerlich W.H., Brechot C., Thomas H.C., Bonino F., De Moura C., Meyer Zum Buschenfelde K.-H.",1688278,Journal of Hepatology,15, 1-2,3,0,0,0,0,3
1992,Mapping of 5' ends of virion-derived HBV DNA,"Saldanha J.A., Qiu H., Thomas H.C., Monjardino J.",426822,Virology,188,1,2,1,0,1,0,3
1992,Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences,"Leahy D., Brown J., Arima T., Maeda E., Todd J.A., Kink J., Byrne R., Shah D., Preisel-Simmons B., Laska S., Dienstag J., Thomas H., Karayiannis P.",411132,Transfusion,32,6,2,0,0,0,0,2
1992,Genetic variation in hepatitis B virus,"Carman W.F., Thomas H.C.",165085,Gastroenterology,102,2,38,0,0,0,0,38
1992,Integration of hepatitis B virus DNA through a mutational hot spot within the cohesive region in a case of hepatocellular carcinoma,"Quade K., Saldanha J., Thomas H., Monjardino J.",221317,Journal of General Virology,73,1,9,0,0,0,0,9
1992,The clinical significance of molecular variation within the hepatitis B virus genome,"Brown J.L., Carman W.F., Thomas H.C.",2709139,Hepatology,15,1,32,2,0,2,0,34
1992,Serological response and detection of viraemia in acute hepatitis C virus infection,"Dourakis S., Mojardino J., Thomas H., Brown J., Kumar U., Karayiannis P., Kernoff P., Chiba J., Ohba H., Miyamura T., Saito I.",1688278,Journal of Hepatology,14, 2-3,7,0,0,0,0,7
1992,Precore sequence variation in Chinese isolates of hepatitis B virus,"Carman W.F., Ferrao M., Lok A.S.F., Ma O.C.K., Lai C.L., Thomas H.C.",221899,Journal of Infectious Diseases,165,1,25,2,0,2,1,28
1992,Cloning and sequencing of the structural region and expression of putative core gene of hepatitis C virus from a British case of chronic sporadic hepatitis,"Kumar U., Cheng D., Thomas H., Monjardino J.",221317,Journal of General Virology,73,6,2,0,0,0,0,2
1992,Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection,"Karayiannis P., Goldin R., Luther S., Carman W.F., Monjardino J., Thomas H.C.",1466615,Journal of Medical Virology,36,4,4,0,0,0,0,4
1992,Interactions of the human immunodeficiency virus and the hepatotropic viruses,"McNair A.N.B., Main J., Thomas H.C.",2728087,Seminars in Liver Disease,12,2,46,4,2,6,0,52
1992,Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease,"Brown J., Dourakis S., Karayiannis P., Goldin R., Chiba J., Ohba H., Miyamura T., Thomas H.C.",2709139,Hepatology,15,2,14,1,0,1,0,15
1992,Does the precore mutant of HBV cause fulminant hepatitis?,Thomas H.C.,2709139,Hepatology,15,1,0,0,0,0,0,0
1992,In situ hybridization studies in hepatitis A infection,"Taylor G.M., Goldin R.D., Karayiannis P., Thomas H.C.",2709139,Hepatology,16,3,1,0,0,0,0,1
1991,Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response,"Waters J.S., Brown S.E., Steward M.W., Howard C.R., Thomas H.C.",1681702,Virus Research,22,1,21,0,2,2,2,25
1991,The host immune response may be responsible for selection of envelope and precore/core variants of HBV,"Thomas H.C., Carman W.F.",1688278,Journal of Hepatology,13,4,2,0,0,0,0,2
1991,Genetically defined variants of hepatitis B virus,"Carman W.F., Thomas H.C.",10529276,Reviews in Medical Virology,1,1,3,0,0,0,0,3
1991,"An in situ hybridization, molecular biological and immunohistochemical study of hepatitis delta virus in woodchucks","Dourakis S., Karayiannis P., Goldin R., Taylor M., Monjardino J., Thomas H.C.",2709139,Hepatology,14,3,1,0,0,0,0,1
1991,A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: Characterization and demonstration of protective immunogenicity,"Karayiannis P., O'Rourke S., McGarvey M.J., Luther S., Waters J., Goldin R., Thomas H.C.",221317,Journal of General Virology,72,9,6,0,0,0,0,6
1991,Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis,"Carman W.F., Fagan E.A., Hadziyannis S., Karayiannis P., Tassopoulos N.C., Williams R., Thomas H.C.",2709139,Hepatology,14,2,74,2,1,3,2,79
1991,"Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-?","Carman W.F., Dourakis S., Karayiannis P., Crossey M., Drobner R., Thomas H.C.",1466615,Journal of Medical Virology,34,2,20,0,0,0,0,20
1991,Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons ? and ? and double-stranded RNA,"Foster G.R., Ackrill A.M., Goldin R.D., Kerr I.M., Thomas H.C., Stark G.R.",278424,Proceedings of the National Academy of Sciences of the United States of America,88,7,68,2,1,3,1,72
1991,Prevention and treatment of hepatitis delta virus infection.,"Karayiannis P., Saldanha J., Monjardino J., Farci P., Thomas H.C.",3617742,Progress in clinical and biological research,364, ,0,1,0,1,0,1
1991,Genetically engineered molecular probes in the study of the natural history of chronic delta hepatitis.,"Monjardino J., Saldanha J., Goldin R., Thomas H.C.",3617742,Progress in clinical and biological research,364, ,0,0,0,0,0,0
1991,Replication of hepatitis B and delta viruses: Appearance of viral mutants,"Foster G.R., Carman W.F., Thomas H.C.",2728087,Seminars in Liver Disease,11,2,1,0,0,0,0,1
1991,Case report. Severe haemolytic transfusion reaction occurring during ?-interferon therapy for chronic hepatitis,"McNair A.N.B., Jacyna M.R., Thomas H.C.",0954691X,European Journal of Gastroenterology and Hepatology,3,2,3,0,0,0,0,3
1991,Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon,"Thomas H.C., Karayiannis P., Brook G.",1688278,Journal of Hepatology,13,1,27,2,3,5,3,35
1991,Cloning and expression of hepatitis delta virus RNA from human serum.,"Saldanha J.A., Thomas H.C., Trepo C., Monjardino J.P.",3617742,Progress in clinical and biological research,364, ,0,0,0,0,0,0
1991,Serum HBV DNA detected by PCR in dot blot negative HBV chronic carriers with active liver disease,"Monjardino J., Velosa J., Thomas H.C., Carneiro de Moura M.",1688278,Journal of Hepatology,13,1,5,0,0,0,0,5
1991,Inhibitory effects of the hepatitis B virus on the cellular response to interferon,"Foster G.R., Ackrill A.M., Golden R.D., Goodbourn S.E., Kerr I.M., Thomas H.C., Stark G.R.",9599673,International Journal of Experimental Pathology,72,4,0,0,0,0,0,0
1991,Prospects in the treatment of viral hepatitis: Introduction,Thomas H.C.,1688278,Journal of Hepatology,13,1,2,0,0,0,0,2
1991,Pathogenesis of chronic active hepatitis B,Thomas H.,8159319,Journal of Gastroenterology and Hepatology,6,1,1,0,0,0,0,1
1990,Immunological studies before and during interferon therapy in chronic HBV infection: Identification of factors predicting response,"Scully L.J., Brown D., Lloyd C., Shein R., Thomas H.C.",2709139,Hepatology,12,5,22,0,0,0,0,22
1990,Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection,"Karayiannis P., Saldanha J., Monjardino J., Goldin R., Main J., Luther S., Easton M., Ponzetto A., Thomas H.C.",2709139,Hepatology,12,5,11,0,0,0,1,12
1990,Parenterally acquired non-A non-B hepatitis ten years on: Advances in diagnosis and therapy,"Jacyna M.R., Thomas H.C.",325473,Postgraduate Medical Journal,66,782,0,0,0,0,0,0
1990,Vaccine-induced escape mutant of hepatitis B virus,"Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A.J., Thomas H.C.",1406736,Lancet,336,8711,385,31,14,45,13,443
1990,The hepatitis B virus,"Brown J.L., Carman W.F., Thomas H.C.",9503528,Bailliere's Clinical Gastroenterology,4,3,4,0,0,0,0,4
1990,The hepatitis B virus and the host response,Thomas H.C.,1688278,Journal of Hepatology,11,1,11,1,0,1,0,12
1990,Hepatitis viruses,"Carman W.F., Thomas H.C.",9503528,Bailliere's Clinical Gastroenterology,4,1,1,0,0,0,0,1
1990,Cloning and sequencing of RNA of hepatitis delta virus isolated from human serum,"Saldanha J.A., Thomas H.C., Monjardino J.P.",221317,Journal of General Virology,71,7,21,0,0,0,0,21
1990,Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia,"Lever A.M.L., Waters J., Brook M.G., Karayiannis P., Thomas H.C.",1406736,Lancet,335,8704,3,0,0,0,0,3
1990,Hepatitis delta virus infection in human immunodeficiency virus-positive patients (I),"Goldin R., Saldanha J., Thomas H.",2709139,Hepatology,11,5,0,0,0,0,0,0
1990,Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment,"Karayiannis P., Kanatakis S., Thomas H.C.",1688278,Journal of Hepatology,10,3,3,0,0,0,0,3
1990,Introduction,Thomas H.C.,3444325,Springer Seminars in Immunopathology,12,1,0,0,0,0,0,0
1990,Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus,"Karayiannis P., Chitranukroh R., Fry M., Petrovic L.M., Moore D., Scheuer P.J., Thomas H.C.",1466615,Journal of Medical Virology,30,2,2,0,0,0,0,2
1990,Cloning and expression of an immunodominant region of the hepatitis delta antigen,"Saldanha J., Homer E., Goldin R., Thomas H.C., Monjardino J.",221317,Journal of General Virology,71,2,2,0,2,2,1,5
1990,Antiviral therapy: Hepatitis B,"Jacyna M.R., Thomas H.C.",71420,British Medical Bulletin,46,2,12,0,0,0,0,12
1990,Hepatitis C virus antibodies in subjects with and without liver disease in the United Kingdom,"Jacyna M.R., O'Neill K., Brown J., Drobner R., Karayiannis P., Thomas H.C.",335622,Quarterly Journal of Medicine,77,282,3,0,0,0,0,3
1990,Haemorrhagic pancreatitis - a cause of death in severe potassium permanganate poisoning,"Middleton S.J., Jacyna M., McClaren D., Robinson R., Thomas H.C.",325473,Postgraduate Medical Journal,66,778,10,0,0,0,1,11
1990,Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection,"Goldin R.D., Fish D.E., Hay A., Waters J.A., McGarvey M.J., Main J., Thomas H.C.",219746,Journal of Clinical Pathology,43,3,29,2,0,2,1,32
1990,Treatment of chronic hepatitis B infection,"Main J., Thomas H.C.",1637258,Pharmacology and Therapeutics,45,3,2,0,0,0,0,2
1990,Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note (I: Reply),"Brook M.G., Karayiannis P., Thomas H.C.",2709139,Hepatology,12,1,0,0,0,0,0,0
1990,Chronic hepatitis B.,"Schalm S.W., Thomas H.C., Hadziyannis S.J.",1060913X,Progress in liver diseases,9, ,22,1,0,1,0,23
1989,Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon,"Farci P., Thomas H.C., Karayiannis P., Brook M.G., Smedile A., Lai M.E., Balestrieri A., Saldanha J.A., Monjardino J., Gerin J.",335622,Quarterly Journal of Medicine,73,271,3,0,0,0,0,3
1989,Pre-S protein in hepatitis B,"Kuijper L., Zuckerman A.J., Koens M., Murray-Lyon I., Coleman J.C., Karayiannis P., Thomas H.C., Zanetti A., Cargnel A., Harrison T.J.",1466615,Journal of Medical Virology,28,1,3,0,0,0,0,3
1989,Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia,"Lee C.A., Kernoff P.B.A., Karayiannis P., Thomas H.C.",71048,British Journal of Haematology,72,2,11,1,0,1,0,12
1989,Defective response to interferons in cells transfected with the hepatitic B virus genome,"Onji M., Lever A.M.L., Saito I., Thomas H.C.",2709139,Hepatology,9,1,12,0,0,0,0,12
1989,Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection,"Carman W.F., Jacyna M.R., Hadziyannis S., Karayiannis P., McGarvey M.J., Makris A., Thomas H.C.",1406736,Lancet,2,8663,476,35,24,59,19,554
1989,Anti-HIV effects of alpha-interferon,"Brook M.G., Gor D., Forster S., Harris J.R.W., Jeffries D.J., Thomas H.C.",1406736,Lancet,1,8628,1,0,0,0,0,1
1989,Studies of GB hepatitis agent in tamarins,"Karayiannis P., Petrovic L.M., Fry M., Moore D., Enticott M., McGarvey M.J., Scheuer P.J., Thomas H.C.",2709139,Hepatology,9,2,24,0,1,1,0,25
1989,Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection,"Brook M.G., Chan G., Yap I., Karayiannis P., Lever A.M.L., Jacyna M., Main J., Thomas H.C.",2670623,British Medical Journal,299,6700,44,3,1,4,0,48
1989,Chronic hepatitis B: Therapeutic controversies and randomised controlled trials,"Schalm S.W., De Man R.A., Thomas H.C., Jacyna M., Hadziyannis S.J., Manessis E.",9505911,Gastroenterology International,2,1,2,0,0,0,0,2
1989,Which patients with chronic hepatitis B virus infection will respond to ?-interferon therapy? A statistical analysis of predictive factors,"Brook M.G., Karayiannis P., Thomas H.C.",2709139,Hepatology,10,5,163,17,8,25,4,192
1989,Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: Implications for the treatment of chronic HBV carriers,Thomas H.C.,335622,Quarterly Journal of Medicine,73,270,5,0,0,0,0,5
1989,Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: Changes during treatment with alpha interferons and predictors of response,"Chen G., Karayiannis P., McGarvey M.J., Lever A.M.L., McDonald J.A., Scully L.J., Kanatakis S., Thomas H.C.",175749,Gut,30,8,2,0,0,0,0,2
1989,Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: Factors that influence response,"Brook M.G., McDonald J.A., Karayiannis P., Caruso L., Forster G., Harris J.R.W., Thomas H.C.",175749,Gut,30,8,43,4,1,5,1,49
1989,Detection of hepatitis delta virus RNA in chronic liver disease,"Saldanha J., Craxi A., Thomas H.C., Monjardino J., Di Blasi F., Blas C., Velosa J., Ramalho F.M., Di Marco V., Mora I., De Moura M.C., Carreno V.",1688278,Journal of Hepatology,9,1,1,0,0,0,0,1
1989,Gallbladder cancer presenting with Trousseau's sign in a 31-year-old man with occupational exposure to aromatic hydrocarbons,"Diggory P., Jacyna M.R., Booth J.C.L., Cook H.T., Thomas H.C.",1410768,Journal of the Royal Society of Medicine,82,10,1,1,0,1,0,2
1989,Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: Three years experience in a London hospital,"Brook M.G., Lever A.M.L., Kelly D., Rutter D., Trompeter R.S., Griffiths P., Thomas H.C.",335622,Quarterly Journal of Medicine,71,264,10,0,0,0,0,10
1989,Immune response of patients with congenital coagulation disorders to hepatitis B vaccine: Suboptimal response and human immunodeficiency virus infection,"Miller E.J., Lee C.A., Karayiannis P., Holmes S., Thomas H.C., Kernoff P.B.A.",1466615,Journal of Medical Virology,28,2,3,0,0,0,1,4
1989,Histological improvement after anti-viral treatment for chronic hepatitis B virus infection,"Brook M.G., Petrovic L., McDonald J.A., Scheuer P.J., Thomas H.C.",1688278,Journal of Hepatology,8,2,19,0,0,0,0,19
1989,Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis,"Jacyna M.R., Brooks M.G., Loke R.H.T., Main J., Murray-Lyon I.M., Thomas H.C.",2670623,British Medical Journal,298,6666,37,0,0,0,0,37
1988,"Management of non A, non B hepatitis: the problem and its treatment.","Thomas H.C., Jacyna M.R., Main J.",0392906X,Chemioterapia,7, ,0,0,0,0,0,0
1988,Virus-host interaction in chronic hepatitis B virus infection,"Thomas H.C., Jacyna M., Waters J., Main J.",2728087,Seminars in Liver Disease,8,4,22,0,0,0,1,23
1988,Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis B,"Brook M.G., Gor D., Forster S.M., Harris W., Jeffries D.J., Thomas H.C.",2699370,AIDS,2,5,4,0,0,0,0,4
1988,Review: the treatment of hepatocellular carcinoma.,"Dunk A.A., Thomas H.C.",2692813,Alimentary Pharmacology and Therapeutics,2,3,0,0,0,0,0,0
1988,Hepatitis B variant in Europe,"Zanetti A.R., Tanzi E., Manzillo G., Maio G., Sbreglia C., Caporaso N., Thomas H., Zuckerman A.J.",1406736,Lancet,2,8620,32,3,4,7,2,41
1988,Non-invasive investigation of liver disease in haemophilic patients,"Miller E.J., Lee C.A., Karayiannis P., Hamilton-Dutoit S.J., Dick R., Thomas H.C., Kernoff P.B.A.",219746,Journal of Clinical Pathology,41,10,1,0,0,0,0,1
1988,"Hepatocellular carcinoma: Clinical, aetiological and pathological features in British patients","Dunk A.A., Spiliadis H., Sherlock S., Fowler M.J.F., Monjardino J.P., Scheuer P.J., Thomas H.C.",207136,International Journal of Cancer,41,1,3,1,0,1,1,5
1988,Acute and chronic hepatitis delta virus infection: Direct or indirect effect on hepatitis B virus replication?,"Farci P., Karayiannis P., Lai M.E., Marongiu F., Orgiana G., Balestrieri A., Thomas H.C.",1466615,Journal of Medical Virology,26,3,0,1,0,1,0,1
1988,Hepatitis B viral infection,Thomas H.C.,29343,American Journal of Medicine,85, 2 A,2,0,0,0,0,2
1988,Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration,"Dunk A.A., Kyprianou N., Davies P., Thomas H.C.",1632116,Digestive Diseases and Sciences,33,4,2,0,0,0,0,2
1987,"Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine","Aldouri M.A., Brown D., Thomas H.C., Wonke B., Hoffbrand A.V., Flynn D.M., Laulicht M., Fenton L.A., Scheuer P.J., Kibbler C.C., Allwood C.A.",219746,Journal of Clinical Pathology,40,11,32,2,6,8,0,40
1987,Treatment of thrombocytopenia with alfa interferon,"Lever A.M.L., Brook M.G., Yap I., Thomas H.C.",2670623,British Medical Journal,295,6612,9,0,0,0,0,9
1987,Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon,"Dunk A.A., Novick D., Thomas H.C.",365521,Scandinavian Journal of Gastroenterology,22,10,8,0,0,0,1,9
1987,"Non-A, non-B hepatitis",Thomas H.C.,335622,Quarterly Journal of Medicine,65,246,0,0,0,0,0,0
1987,Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomas.,"Brook M.G., Dunk A.A., McDonald J.A., Lever A.M., Goh C., Thomas H.C.",2692813,Alimentary Pharmacology and Therapeutics,1,4,2,0,0,0,0,2
1987,In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5,"Dunk A.A., Brown D., Weidmann K., Thomas H.C.",1688278,Journal of Hepatology,4,1,3,0,0,0,0,3
1987,Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.,"Thomas H.C., Farci P., Shein R., Karayiannis P., Smedile A., Caruso L., Gerin J.",3617742,Progress in clinical and biological research,234, ,5,0,0,0,0,5
1987,Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen display,"McDonald J.A., Harris S., Waters J.A., Thomas H.C.",1688278,Journal of Hepatology,4,3,19,3,0,3,1,23
1987,Cloning and characterisation of a delta virus cDNA sequence derived from a human source,"Saldanha J.A., Thomas H.C., Monjardino J.P.",1466615,Journal of Medical Virology,22,4,0,0,0,0,0,0
1987,Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis,"Farci P., Burroughs A.K., Thomas H.C., Shamma'a M.",1688278,Journal of Hepatology,4,2,2,1,0,1,0,3
1987,Use of biotinylated probes in serum hepatitis B virus DNA detection,"Saldanha J.A., Karayiannis P., Thomas H.C., Monjardino J.P.",1660934,Journal of Virological Methods,16,4,1,0,0,0,0,1
1987,Human hepatocellular carcinoma: Cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells,"Wiedmann K.H., Trejdosiewicz L.K., Southgate J., Thomas H.C.",2709139,Hepatology,7,3,1,1,0,1,0,2
1987,Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant ?-interferon in hepatitis-B carriers,"McDonald E.M., Mann A.H., Thomas H.C.",1406736,Lancet,2,8569,116,6,4,10,2,128
1987,Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen,"Ishihara K., Waters J.A., Pignatelli M., Thomas H.C.",1466615,Journal of Medical Virology,21,1,4,0,0,0,0,4
1986,Lymphoblastoid and recombinant ?-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience,"Thomas H.C., Scully L.J., McDonald J.A.",1688278,Journal of Hepatology,3,2,2,0,0,0,0,2
1986,Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection,"Ikeda T., Pignatelli M., Lever A.M.L., Thomas H.C.",175749,Gut,27,12,1,0,0,0,0,1
1986,Hepatocellular carcinoma: Clinical and prognostic features in British residents,"Dunk A.A., Thomas H.C., Sherlock S.",369330,Scottish Medical Journal,31,4,0,0,0,0,0,0
1986,Delta virus hepatitis,"Sherlock S., Thomas H.C.",1688278,Journal of Hepatology,3,3,0,0,0,0,0,0
1986,Round table discussion on future developments,"Wright R., Williams R., de Moura M.C., Omata M., Eddleston A.L.W.F., Schalm S.W., Hoofnagle J.H., Thomas H.C., Trepo C.",1688278,Journal of Hepatology,3,2,0,0,0,0,0,0
1986,Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life,"Ikeda T., Lever A.M.L., Thomas H.C.",2709139,Hepatology,6,5,40,1,0,1,0,41
1986,Approaches to the treatment of hepatitis B virus and delta-related liver disease,"Thomas H.C., Lever A.M.L., Scully L.J., Pignatelli M.",2728087,Seminars in Liver Disease,6,1,5,0,0,0,0,5
1986,Cloning and analysis of integrated hepatitis B virus DNA of the adr subtype derived from a human primary liver cell carcinoma,"Fowler M.J.F., Thomas H.C., Monjardino J.",221317,Journal of General Virology,67,4,4,0,0,0,0,4
1986,Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma,"Dunk A.A., Ikeda T., Pignatelli M., Thomas H.C.",1688278,Journal of Hepatology,2,3,29,3,0,3,2,34
1986,Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus,"Waters J.A., Jowett T.P., Thomas H.C.",1466615,Journal of Medical Virology,19,1,2,0,0,0,0,2
1986,Homology between HBV-DNA and a sequence regulating the interferon-induced antiviral system: Possible mechanism of persistent infection,"Thomas H.C., Pignatelli M., Lever A.M.L.",1466615,Journal of Medical Virology,19,1,2,0,0,0,0,2
1985,Viruses and immune reactions in the liver,"Thomas H.C., Pignatelli M., Scully L.J.",855928,"Scandinavian Journal of Gastroenterology, Supplement",20,114,2,0,0,0,0,2
1985,Management of primary biliary cirrhosis,Thomas H.C.,327611,Prescribers' Journal,25,6,0,0,0,0,0,0
1985,Treatment of chronic hepatitis due to hepatitis B virus,"Sherlock S., Thomas H.C.",1406736,Lancet,2,8468,2,1,0,1,0,3
1985,Antiviral therapy in hepatitis B infection,"Thomas H.C., Scully L.J.",71420,British Medical Bulletin,41,4,10,0,0,0,0,10
1985,Clinical and histological features of delta infection in chronic hepatitis B virus carriers,"Lok A.S.F., Lindsay I., Scheuer P.J., Thomas H.C.",219746,Journal of Clinical Pathology,38,5,10,0,0,0,0,10
1985,Expression of beta-2-microglobulin on hepatocytes after liver transplantation,"Nagafuchi Y., Thomas H.C., Hobbs K.E.F., Scheuer P.J.",1406736,Lancet,1,8428,6,0,0,0,0,6
1985,Protection against hepatitis B virus infection by immunization with hepatitis B core antigen,"Iwarson S., Tabor E., Thomas H.C.",165085,Gastroenterology,88,3,30,2,1,3,0,33
1985,The delta agent comes of age,Thomas H.C.,175749,Gut,26,1,0,0,0,0,0,0
1985,Psychological impact of chronic infection with hepatitis B virus on British patients,"Lok A.S.F., Van Leeuwen D.J., Thomas H.C., Sherlock S.",2664348,Genitourinary Medicine,61,4,6,1,1,2,1,9
1985,"Non-A, non-B hepatitis after intravenous gammaglobulin","Lever A.M.L., Webster A.D.B., Brown D., Thomas H.C.",1406736,Lancet,1,8428,2,0,0,0,0,2
1985,Clinical uses of HBV-DNA assays,"Thomas H.C., Karayiannis P., Fowler M.J.F., Monjardino J.",1660934,Journal of Virological Methods,10,4,0,0,0,0,0,0
1985,Analysis of the antigenic composition of liver specific lipoprotein using murine monoclonal antibodies,"Wiedmann K.H., Trejdosiewicz L.K., Goodall A.H., Thomas H.C.",175749,Gut,26,5,0,0,0,0,0,0
1985,Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease,"Novick D.M., Lok A.S.F., Thomas H.C.",1688278,Journal of Hepatology,1,1,2,0,0,0,0,2
1985,Is modulation of HLA display by interferon important in preventing the development of the chronic carrier state of hepatitis B virus in adults?,"Thomas H.C., Pignatelli M.",3998320,Gastroenterologie Clinique et Biologique,9,4,0,0,0,0,0,0
1985,Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: An experimental study in the chimpanzee,"Iwarson S., Tabor E., Thomas H.C.",1466615,Journal of Medical Virology,16,1,24,2,1,3,0,27
1985,High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effects of prophylactic immune serum globulin,"Kernoff P.B.A., Lee C.A., Karayiannis P., Thomas H.C.",71048,British Journal of Haematology,60,3,51,4,1,5,2,58
1985,"Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate","Lee C.A., Kernoff P.B.A., Karayiannis P., Thomas H.C.",175749,Gut,26,6,2,0,0,0,0,2
1984,"Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin","Lever A.M.L., Webster A.D.B., Brown D., Thomas H.C.",1406736,Lancet,2,8411,46,1,1,2,1,49
1984,Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection,"Lok A.S.F., Wilson L.A., Thomas H.C.",3057453,Journal of Antimicrobial Chemotherapy,14,1,5,0,0,0,1,6
1984,Antiviral treatment of chronic hepatitis B virus infection,"Novick D.M., Thomas H.C.",1410768,Journal of the Royal Society of Medicine,77,12,0,0,0,0,0,0
1984,The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyte,"Galpin S.A., Karayiannis P., Middleton S.M., Thomas H.C.",1466615,Journal of Medical Virology,14,3,2,0,0,0,0,2
1984,Liver membrane antibodies detected by immunoradiometric assay in acute and chronic virus-induced and autoimmune liver disease,"Wiedmann K.H., Bartholomew T.C., Brown D.J.C., Thomas H.C.",2709139,Hepatology,4,2,2,0,0,0,0,2
1984,Hepatitis B virus and host cell membrane antigens on a primary hepatocellular carcinoma cell line,"De Koning R.W., Goodall A., Varghese Z., Thomas H.C.",1069543,Liver,4,1,0,0,0,0,0,0
1983,Epidemiology and clinical course of delta infection in Britain.,"Lok A.S., Farci P., Thomas H.C.",3617742,Progress in clinical and biological research,143, ,0,0,0,0,0,0
1983,Treatment of chronic hepatitis B virus infection,"Thomas H.C., Weller I.V.D.",3906663,Clinical and Experimental Obstetrics and Gynecology,10,1,0,0,0,0,0,0
1983,Hepatitis B virus infection: The impact of molecular biology,"Sherlock S., Thomas H.C.",2709139,Hepatology,3,3,2,0,0,0,0,2
1983,Recent advances in viral hepatitis,Thomas H.C.,325473,Postgraduate Medical Journal,59,4,0,0,0,0,0,0
1983,"Defective hepatitis B virus DNA molecules detected in a stable integration pattern in a hepatoma cell line, and in induced tumours and derived cell lines","Monjardino J.P., Fowler M.J.F., Thomas H.C.",221317,Journal of General Virology,64,10,2,0,0,0,1,3
1983,Growth characteristics of ?-foetoprotein-secreting human hepatocellular carcinoma in athymic (nude) mice,"Bassendine M.F., Wright N.A., Thomas H.C., Sherlock S.",1435221,Clinical Science,64,6,0,0,0,0,0,0
1983,"Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: Clinical and epidemiological features","Bamber M., Thomas H.C., Bannister B., Sherlock S.",175749,Gut,24,6,5,0,0,0,0,5
1982,A comparative study of the biliary secretion of human dimeric and monomeric IgA in the rat and in man,"Dooley J.S., Potter B.J., Thomas H.C., Sherlock S.",2709139,Hepatology,2,3,3,0,0,0,0,3
1982,"T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: A review of the abnormalities and the effects of treatment","Thomas H.C., Brown D., Labrooy J., Epstein O.",2719142,Journal of Clinical Immunology,2,3,2,0,1,1,0,3
1982,Immunological mechanisms in chronic hepatitis B virus infection,"Thomas H.C., Montano L., Goodall A.",2709139,Hepatology,2,2,23,0,1,1,0,24
1982,Inducer and suppressor T-cells in hepatitis B virus-induced liver disease,"Thomas H.C., Brown D., Routhier G.",2709139,Hepatology,2,2,8,0,1,1,0,9
1982,T-cell subsets in autoimmune and HBV-induced chronic liver disease: A review of the abnormalities and the effects of treatment,"Thomas H.C., Brown D., Labrooy J., Epstein O.",1069543,Liver,2,3,2,0,0,0,0,2
1982,Inhibition of hepatitis B viral replication by lymphoblastoid interferon.,"Weller I.V., Fowler M.J., Monjardino J., Carreno V., Thomas H.C., Sherlock S.",9628436,Philosophical transactions of the Royal Society of London. Series B: Biological sciences,299,1094,0,0,0,0,0,0
1982,"Relatedness of non-A, non-B hepatitis viruses.","Monjardino J., Fowler M.J., Thomas H.C.",1406736,Lancet,2,8290,0,0,0,0,0,0
1982,Genetic and sex-linked factors influencing HBs antigen clearance. I. Nonimmune clearance in inbred strains of mice,"Craxi A., Montano L., Goodall A., Thomas H.C.",1466615,Journal of Medical Virology,9,2,7,0,0,0,0,7
1982,The detection of HBV-DNA in serum by molecular hybridisation: A more sensitive method for the detection of complete HBV particles,"Weller I.V.D., Fowler M.J.F., Monjardino J., Thomas H.C.",1466615,Journal of Medical Virology,9,4,13,0,0,0,0,13
1981,Genetic factors in determining susceptibility to alcohol dependence and development of alcohol-induced liver disease,"Jenkins W.J., Thomas H.C.",3005089,Clinics in Gastroenterology,10,2,0,0,0,0,0,0
1981,Introduction,Thomas H.C.,3444325,Springer Seminars in Immunopathology,3,4,0,0,0,0,0,0
1981,"T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease",Thomas H.C.,1920561,International Journal of Immunopharmacology,3,3,4,0,0,0,0,4
1981,Is mitochondrial antibody diagnostic of primary biliary cirrhosis?,"Munoz L.E., Thomas H.C., Scheuer P.J.",175749,Gut,22,2,24,0,1,1,1,26
1981,Primary liver cell cancer in autoimmune chronic liver disease,"Burroughs A.K., Bassendine M.F., Thomas H.C., Sherlock S.",9598146,British Medical Journal,282,6260,7,1,0,1,0,8
1981,"Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrations in patients with congenital coagulation disorders: A preliminary report of an antigen/antibody system","Bamber M., Murray A., Kernoff P.B.A., Thomas H.C.",3083616,Medical Laboratory Sciences,38,4,1,0,0,0,0,1
1980,Immunological and anti-viral therapy of chronic hepatitis B virus infection,"Thomas H.C., Bassendine M.F.",3005089,Clinics in Gastroenterology,9,1,0,0,0,0,0,0
1980,Introduction,Thomas H.C.,3444325,Springer Seminars in Immunopathology,3,3,0,0,0,0,0,0
1980,Pathogenic mechanisms in primary biliary cirrhosis,"Thomas H.C., Epstein O.",3444325,Springer Seminars in Immunopathology,3,3,0,0,0,0,0,0
1980,Cyclosporin A in primary biliary cirrhosis,"Thomas H.C., Routhier G., Epstein O.",165085,Gastroenterology,79,5,0,0,0,0,0,0
1980,Complement metabolism in chronic liver disease: Catabolism in C1q in chronic active liver disease and primary biliary cirrhosis,"Potter B.J., Elias E., Thomas H.C., Sherlock S.",165085,Gastroenterology,78, 5 I,4,0,0,0,0,4
1980,Bile duct carcinoma: A late complication of congenital hepatic fibrosis. Case report and review of literature,"Scott J., Shousha S., Thomas H.C., Sherlock S.",29270,American Journal of Gastroenterology,73,2,12,2,5,7,1,20
1979,The immunological effects of thymectomy in myasthenia gravis,"Scadding G.K., Thomas H.C., Havard C.W.H.",99104,Clinical and Experimental Immunology,36,2,2,0,0,0,0,2
1979,"Metabolism of the third component of complement in acute type B hepatitis, HBs antigen positive glomerulonephritis, polyarteritis nodosum, and HBs antigen positive and negative chronic active liver disease","Thomas H.C., Potter B.J., Elias E., Sherlock S.",165085,Gastroenterology,76,4,0,0,0,0,0,0
1978,Immune complexes in acute and chronic liver disease,"Thomas H.C., De Villiers D., Potter B.",99104,Clinical and Experimental Immunology,31,2,3,0,0,0,0,3
1978,Trial of ribavirin for the treatment of HBsAg positive chronic liver disease,"Jain S., Thomas H.C., Oxford J.S., Sherlock S.",3057453,Journal of Antimicrobial Chemotherapy,4,4,4,0,0,0,0,4
1978,e Antigen in agammaglobulinaemia.,"Chadwick R.G., Thomas H.C., Sherlock S.",1406736,Lancet,1,8064,0,0,0,0,0,0
1978,In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis,"Vincent A., Scadding G.K., Thomas H.C., Newsom-Davis J.",1406736,Lancet,1,8059,18,1,2,3,1,22
1977,Levamisole in the treatment of HB(s) antigen positive chronic active liver disease,"Thomas H.C., Chadwick G., Jain S., Sherlock S.",165085,Gastroenterology,73,5,0,0,0,0,0,0
1977,Is primary biliary cirrhosis an immune complex disease?,"Thomas H.C., Potter B.J., Sherlock S.",1406736,Lancet,2,8051,5,0,0,0,0,5
1977,Transfer factor in the attempted treatment of patients with HBs-Ag-positive chronic liver disease,"Jain S., Thomas H.C., Sherlock S.",99104,Clinical and Experimental Immunology,30,1,0,0,0,0,0,0
1977,Levamisole in the treatment of HBs antigen positive chronic active liver disease,"Chadwick R.G., Jain S., Thomas H.C., Sherlock S.",175749,Gut,18,11,0,0,0,0,0,0
1977,Levamisole in the treatment of HBs antigen-positive chronic active liver disease,"Thomas H.C., Chadwick G., Jain S., Sherlock S.",122823,Digestion,16,4,0,0,0,0,0,0
1977,Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease,"Sanchez Tapias J., Thomas H.C., Sherlock S.",175749,Gut,18,6,2,1,0,1,0,3
1977,Serum alpha fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma,"Eleftheriou N., Heathcote J., Thomas H.C., Sherlock S.",219746,Journal of Clinical Pathology,30,8,7,0,1,1,0,8
1977,The immune response in hepatic cirrhosis: animal and human studies,Thomas H.C.,359157,Proceedings of the Royal Society of Medicine,70,8,1,0,1,1,0,2
1977,Myasthenia gravis: acetylcholine receptor antibody titres after thymectomy,"Scadding G.K., Thomas H.C., Havard C.W.H.",9598146,British Medical Journal,1,6075,3,0,0,0,0,3
1976,Failure of transfer factor therapy in chronic active type B hepatitis,"Jain S., Thomas H., Sherlock S.",284793,New England Journal of Medicine,295,9,0,0,0,0,0,0
1976,Peripheral blood lymphocyte populations in chronic liver disease,"Thomas H.C., Freni M., Sanchez Tapias J.",99104,Clinical and Experimental Immunology,26,2,2,0,0,0,0,2
1976,Double stranded DNA binding capacity of serum in acute and chronic liver disease,"Jain S., Markham R., Thomas H.C., Sherlock S.",99104,Clinical and Experimental Immunology,26,1,4,0,0,0,0,4
1976,The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens,"Thomas H.C., Ryan C.J., Benjamin I.S.",165085,Gastroenterology,71,1,14,1,0,1,0,15
1976,Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis,"Thomas H.C., Holden R., Verrier Jones J., Peacock D.B.",175749,Gut,17,11,4,0,1,1,0,5
1976,Proceedings: C3 metabolism in HBsAg positive and negative chronic active liver disease (CALD).,"Elias E., Potter B.J., Thomas H.C., Sherlock S.",175749,Gut,17,5,0,0,0,0,0,0
1975,Antibodies to Escherichia coli in chronic liver diseases,"Simjee A.E., Hamilton Miller J.M.T., Thomas H.C.",175749,Gut,16,11,1,0,0,0,0,1
1975,Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease,"Eleftheriou N., Thomas H.C., Heathcote J., Sherlock S.",1406736,Lancet,2,7946,4,0,0,0,0,4
1975,Proceedings: The effect of lymphocytic transfer factor on hepatitis B surface antigen-positive chronic liver disease.,"Jain S., Thomas H.C., Sherlock S.",175749,Gut,16,10,0,0,0,0,0,0
1975,Proceedings: Lymphocyte populations in chronic liver disease.,"Thomas H.C., Sanchez-Tapias J., Freni M.A., Jain S., Sherlock S.",175749,Gut,16,10,0,0,0,0,0,0
1975,Proceedings: Primary and secondary immune responses to phiX 174 in patients with primary biliary cirrhosis and chronic active hepatitis.,"Thomas H.C., Holden R., Verrier-Jones J., Peacock D.",175749,Gut,16,10,0,0,0,0,0,0
1975,Proceedings: Serum alphafetoprotein levels in liver disease: relation to hepatocellular regeneration and development of hepatoma.,"Eleftheriou N., Thomas H., Heathcote J., Sherlock S.",175749,Gut,16,10,2,0,0,0,0,2
1974,The induction of tolerance to a soluble protein antigen by oral administration,"Thomas H.C., Parrott D.M.V.",192805,Immunology,27,4,49,0,1,1,1,51
1974,Homeostatic mechanism for the removal of antigen from the portal circulation,"Thomas H.C., Vaez Zadeh F.",192805,Immunology,26,2,1,0,0,0,0,1
1974,Proceedings: Viral and bacterial antibodies in primary biliary cirrhosis and other chronic liver disease.,"Thomas H.C., Holden R., Ironside J., Somerville R.G.",175749,Gut,15,10,0,0,0,0,0,0
1973,An assessment of the capacity of the liver to remove antigen from the portal circulation in normal and cirrhotic rats.,"Thomas H.C., Macsween R.N.",175749,Gut,14,5,0,0,0,0,0,0
